Clinicopathologic and molecular characteristics of Chinese lung adenocarcinoma patients with EGFR exon 20 insertion mutations

BACKGROUND: Epidermal growth factor receptor exon 20 insertions (EGFR ex20ins) occur in about 4–14% of lung adenocarcinoma (LUAD) patients with EGFR mutations. Recently some targeted drugs have been approved for the treatment of LUAD patients with EGFR ex20ins. However, the heterogeneity of EGFR ex2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lifeng, Liu, Zichen, Wan, Zhiyi, Jiang, Dong, Zhang, Min, Liu, Shuku, Che, Nanying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908167/
https://www.ncbi.nlm.nih.gov/pubmed/35280421
http://dx.doi.org/10.21037/atm-22-383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908167/
https://www.ncbi.nlm.nih.gov/pubmed/35280421
http://dx.doi.org/10.21037/atm-22-383

Ejemplares similares